Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab
Author:
Publisher
Frontiers Media SA
Subject
General Medicine
Reference34 articles.
1. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus assessment group biologics register;McCarthy;Rheumatology.,2018
2. Biologics in systemic lupus erythematosus: current options and future perspectives;Md Yusof;Br J Hosp Med.,2014
3. B cell biomarkers of rituximab responses in systemic lupus erythematosus;Vital;Arthritis Rheum.,2011
4. Use of rituximab in systemic lupus erythematosus: a single center experience over 14 years;Aguiar;Arthritis Care Res.,2017
5. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts;Diaz-Lagares;Autoimmun Rev.,2012
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Innovations in Cutaneous Lupus;Dermatologic Clinics;2024-09
2. Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update;Seminars in Arthritis and Rheumatism;2024-04
3. Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus;Life;2023-07-01
4. Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis;Renal Failure;2023-05-17
5. Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus;Rheumatology;2022-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3